Inactivated hepatitis A vaccine: long-term antibody persistence

By Wiedermann G.   Kundi M.   Ambrosch F.   Safary A.   D'Hondt E.   Delem A.  

Vaccine, Vol. 15, Iss. 6, 1997-04 ,pp. : 612-615

Elsevier

Access to resources Recommend Favorite

Long-term persistence of anti-HBs after vaccination with a recombinant DNA yeast-derived hepatitis B vaccine: 8-year results

By Van Herck K.   Van Damme P.   Thoelen S.   Meheus A.  

Vaccine, Vol. 16, Iss. 20, 1998-12 ,pp. : 1933-1935

Elsevier

Access to resources Recommend Favorite

Quantification of hepatitis B vaccine-induced antibodies as a predictor of anti-HBs persistence

By Gesemann M.   Scheiermann N.  

Vaccine, Vol. 13, Iss. 5, 1995-01 ,pp. : 443-447

Elsevier

Access to resources Recommend Favorite

Persistence of anti-HBs antibodies in health care personnel vaccinated with plasma-derived hepatitis B vaccine and response to recombinant DNA HB booster vaccine

By Trivello R.   Chiaramonte M.   Ngatchu T.   Baldo V.   Majori S.   Moschen M.E.   Simoncello I.   Renzulli G.   Naccarato R.  

Vaccine, Vol. 13, Iss. 2, 1995-02 ,pp. : 139-141

Elsevier

Access to resources Recommend Favorite

Long-term duration of detectable neutralizing antibodies after administration of live-attenuated VEE vaccine and following booster vaccination with inactivated VEE vaccine

By Pittman P.R.   Makuch R.S.   Mangiafico J.A.   Cannon T.L.   Gibbs P.H.   Peters C.J.  

Vaccine, Vol. 14, Iss. 4, 1996-03 ,pp. : 337-343

Elsevier

Access to resources Recommend Favorite